PCN150 - COST-EFFECTIVENESS ANALYSIS OF PHARMACOKINETIC-GUIDED (PK) 5-FLUOROURACIL (5-FU) DOSING WHEN COMBINED WITH LEUCOVORIN, IRINOTECAN AND OXALIPLATIN (FOLFIRINOX) CHEMOTHERAPY FOR ADVANCED PANCREAS CANCER
Oct 1, 2018, 00:00 AM
10.1016/j.jval.2018.09.233
https://www.valueinhealthjournal.com/article/S1098-3015(18)33533-2/fulltext
Section Title :
Section Order :
1728
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33533-2&doi=10.1016/j.jval.2018.09.233